Literature DB >> 8022041

Determination of measles, mumps, and rubella immunization status using oral fluid samples.

T Thieme1, S Piacentini, S Davidson, K Steingart.   

Abstract

OBJECTIVE: To determine if oral fluid samples can be used to reliably assess protective blood levels of antibodies to measles, mumps, and rubella.
DESIGN: A comparison of matched serum and oral fluid samples from asymptomatic subjects in enzyme-linked immunosorbent assays for measles, mumps, and rubella antibodies. A longitudinal study compared matched serum and oral fluid samples from 11 subjects after measles-mumps-rubella vaccination.
SETTING: Five US clinical sites with samples tested at the reporting laboratory. PARTICIPANTS: A total of 157 asymptomatic subjects including 55 subjects younger than 18 years. MAIN OUTCOME MEASURES AND
RESULTS: The presence of antibodies in oral fluid specimens correlated with that in serum with the following levels of sensitivity and specificity: measles, 97% and 100%, respectively; mumps, 94% and 94%, respectively; rubella, 98% and 98%, respectively. Longitudinal studies of subjects after vaccination showed similar seroconversion profiles in oral fluid and serum samples.
CONCLUSION: Protective blood levels of antibodies to measles, mumps, and rubella can be assessed by means of an oral fluid sample with good reliability.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8022041

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  9 in total

1.  Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts.

Authors:  K Vainio; H H Samdal; G Anestad; E Wedege; D H Skutlaberg; K T Bransdal; R Mundal; I S Aaberge
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-22       Impact factor: 3.267

2.  Measles immunity and response to revaccination among secondary school children in Cumbria.

Authors:  N Calvert; F Cutts; R Irving; D Brown; J Marsh; E Miller
Journal:  Epidemiol Infect       Date:  1996-02       Impact factor: 2.451

3.  Rapid detection of lactate dehydrogenase and genotyping of Plasmodium falciparum in saliva of children with acute uncomplicated malaria.

Authors:  Grace O Gbotosho; Christian T Happi; Onikepe Folarin; Ochuko Keyamo; Akintunde Sowunmi; Ayoade M J Oduola
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

4.  New, ultrasensitive enzyme immunoassay for detecting vaccine- and disease-induced hepatitis A virus-specific immunoglobulin G in saliva.

Authors:  J J Ochnio; D W Scheifele; M Ho; L A Mitchell
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

5.  Detection of immunoglobulin G and A antibodies to rubella virus in urine and antibody responses to vaccine-induced infection.

Authors:  S Takahashi; F Machikawa; A Noda; T Oda; T Tachikawa
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

6.  Comparison of conventional and non-invasive diagnostic tools for detecting Plasmodium falciparum infection in southwestern Cameroon: a cross-sectional study.

Authors:  Tobias O Apinjoh; Veronica N Ntasin; Phil Collins C Tataw; Vincent N Ntui; Dieudonne L Njimoh; Fidelis Cho-Ngwa; Eric A Achidi
Journal:  Infect Dis Poverty       Date:  2021-05-22       Impact factor: 4.520

7.  Salivary Genomics, Transcriptomics and Proteomics: The Emerging Concept of the Oral Ecosystem and their Use in the Early Diagnosis of Cancer and other Diseases.

Authors:  T K Fábián; P Fejérdy; P Csermely
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

Review 8.  Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs.

Authors:  Peter A C Maple
Journal:  Vaccines (Basel)       Date:  2015-12-09

9.  Detection of Entamoeba histolytica DNA in the saliva of amoebic liver abscess patients who received prior treatment with metronidazole.

Authors:  Krishna Khairnar; Subhash Chandra Parija
Journal:  J Health Popul Nutr       Date:  2008-12       Impact factor: 2.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.